NCT02808351View on ClinicalTrials.gov

Berberine Prevent Contrast-induced Nephropathy in Patients With Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Diabetes MellitusChronic Kidney Disease
Interventions
DRUG

Berberine

Trial Locations (1)

210006

Nanjing First Hospital, Nanjing

All Listed Sponsors
lead

Nanjing First Hospital, Nanjing Medical University

OTHER

NCT02808351 - Berberine Prevent Contrast-induced Nephropathy in Patients With Diabetes | Biotech Hunter | Biotech Hunter